MaryCDinauerMD
Pediatric Hematology & Oncology • Saint Louis, MOProfessor, Pediatrics, Washington University School of Medicine
Are you Dr. Dinauer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 58 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Childrens Pl
Div Ped Hematology Onc Ste 9S
Saint Louis, MO 63110Phone+1 314-454-6018Fax+1 844-621-4392
Summary
- Dr. Mary Dinauer, MD is a pediatric hematologist/oncologist in Saint Louis, Missouri. She is currently licensed to practice medicine in Missouri, Indiana, and California. She is a Professor at Washington University School of Medicine.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1985 - 1989
University of California (San Francisco)Residency, Pediatrics, 1981 - 1985
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1983 - Present
MO State Medical License 2012 - 2024
IN State Medical License 1991 - 2011- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
Publications & Presentations
PubMed
- 131 citationsLupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidaseChaim O. Jacob, Miriam Eisenstein, Mary C. Dinauer, Wenyu Ming, Qiang Liu
Proceedings of the National Academy of Sciences of the United States of America. 2012-01-10 - 13 citationsHyper-responsive Toll-like receptor 7 and 9 activation in NADPH oxidase-deficient B lymphoblastsShawna McLetchie, Bryan D. Volpp, Mary C. Dinauer, Janice S. Blum
Immunology. 2015-12-01 - 762 citationsMouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide productionJonathan D. Pollock, David A. Williams, Mary A.C. Gifford, Ling Lin Li, Xunxiang Du
Nature Genetics. 1995-01-01
Press Mentions
Tumor Selective Uptake of Drug-Nanodiamond Complexes Improves Therapeutic Outcome in Pancreatic CancerMay 8th, 2019
Grant Support
- Gene Therapy Of X-Linked Chronic Granulomatous DiseaseNational Heart, Lung, And Blood Institute1995–2009
- Gene Replacement Therapy In Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1995–2009
- Structure/Function Analysis Of Phagocyte ProteinsNational Heart, Lung, And Blood Institute1991–2009
- 2005 Phagocytes Gordon ConferenceNational Institute Of Allergy And Infectious Diseases2005
- AdministrativeNational Heart, Lung, And Blood Institute2005
- Core C- Administrative CoreNational Heart, Lung, And Blood Institute2004
- Regulation Of Phagocyte Function By RAC2National Heart, Lung, And Blood Institute2002
- Gene Therapy Of X-Linked Chronic Granulomatous DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1998
- Murine Model Of X Linked Chronic Granulomatous DiseaseNational Heart, Lung, And Blood Institute1994–1998
- Structure-Function Analysis Of Phagocyte ProteinsNational Heart, Lung, And Blood Institute1994–1995
- Molecular Studies Of Phagocyte Oxidase B-CytochromeNational Heart, Lung, And Blood Institute1992–1993
- Structure/Function Analysis Of Phagocyte ProteinsNational Heart, Lung, And Blood Institute1991
- Molecular Studies Of Phagocyte Oxidase B-CytochromeNational Heart, Lung, And Blood Institute1989–1991
